Mandate

Vinge advises First State Investments on acquisition of E.ON Gas Sverige AB.

April 27, 2018 M&A

Vinge has advised European Diversified Infrastructure Fund II ("EDIF II"), an infrastructure fund managed by First State Investments, in connection with the acquisition of E.ON Gas Sverige AB.

E.ON Gas Sverige AB is the part of E.ON Sverige AB which owns gas networks. First State Investments is a global fund manager with more than 20 years of infrastructure investment experience. EDIF II, where investors are predominantly European pension funds, focuses on long-term investments in European infrastructure companies.

The Vinge team advising First State Investments includes Christoffer Thalin together with Kristoffer Franzkeit, Niklas Törnell, Anna Jonson, Anna Thuresson, Henrik Borna, Freja Ljungdell Kristensen, Daniel Melander Björner, Mathias Lindquist, Jack Bengtsson and Emelie Svensäter Jerntorp. Henrik Ossborn and Fredrik Christiansson advised on the financing of the transaction. Björn Mullaart and Rickard Vernet provided competition law advice.


 

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026